Global Chorea Treatment Market Insights, Forecast to 2029

Publisher Name :
Date: 19-Jun-2023
No. of pages: 112
Inquire Before Buying

Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.

Market Analysis and Insights: Global Chorea Treatment Market

The global Chorea Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chorea Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Chorea Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Chorea Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Chorea Treatment include Medtronic, Boston Scientific, Aleva Neurotherapeutics, Teva Pharmaceutical, Pfizer, GlaxoSmithKline, Bausch Health Companies, LivaNova and Lundbeck, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Chorea Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Chorea Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Chorea Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chorea Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Chorea Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Chorea Treatment revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Medtronic, Boston Scientific, Aleva Neurotherapeutics, Teva Pharmaceutical, Pfizer, GlaxoSmithKline, Bausch Health Companies, LivaNova and Lundbeck, etc.

By Company

- Medtronic

- Boston Scientific

- Aleva Neurotherapeutics

- Teva Pharmaceutical

- Pfizer

- GlaxoSmithKline

- Bausch Health Companies

- LivaNova

- Lundbeck

- Ipsen

- Alnylam Pharmaceuticals

- Prana Biotechnology

- RespireRx Pharmaceuticals

- Vertex Pharmaceuticals

- SOM Biotech

Segment by Type

- Medication

- Surgery Therapy

Segment by Application

- Hospitals

- Clinics

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Chorea Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chorea Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chorea Treatment revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Chorea Treatment Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chorea Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Medication
1.2.3 Surgery Therapy
1.3 Market by Application
1.3.1 Global Chorea Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chorea Treatment Market Perspective (2018-2029)
2.2 Global Chorea Treatment Growth Trends by Region
2.2.1 Chorea Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chorea Treatment Historic Market Size by Region (2018-2023)
2.2.3 Chorea Treatment Forecasted Market Size by Region (2024-2029)
2.3 Chorea Treatment Market Dynamics
2.3.1 Chorea Treatment Industry Trends
2.3.2 Chorea Treatment Market Drivers
2.3.3 Chorea Treatment Market Challenges
2.3.4 Chorea Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Chorea Treatment by Players
3.1.1 Global Chorea Treatment Revenue by Players (2018-2023)
3.1.2 Global Chorea Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Chorea Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Chorea Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Chorea Treatment Market Concentration Ratio
3.4.1 Global Chorea Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chorea Treatment Revenue in 2022
3.5 Global Key Players of Chorea Treatment Head office and Area Served
3.6 Global Key Players of Chorea Treatment, Product and Application
3.7 Global Key Players of Chorea Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chorea Treatment Breakdown Data by Type
4.1 Global Chorea Treatment Historic Market Size by Type (2018-2023)
4.2 Global Chorea Treatment Forecasted Market Size by Type (2024-2029)
5 Chorea Treatment Breakdown Data by Application
5.1 Global Chorea Treatment Historic Market Size by Application (2018-2023)
5.2 Global Chorea Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chorea Treatment Market Size (2018-2029)
6.2 North America Chorea Treatment Market Size by Type
6.2.1 North America Chorea Treatment Market Size by Type (2018-2023)
6.2.2 North America Chorea Treatment Market Size by Type (2024-2029)
6.2.3 North America Chorea Treatment Market Share by Type (2018-2029)
6.3 North America Chorea Treatment Market Size by Application
6.3.1 North America Chorea Treatment Market Size by Application (2018-2023)
6.3.2 North America Chorea Treatment Market Size by Application (2024-2029)
6.3.3 North America Chorea Treatment Market Share by Application (2018-2029)
6.4 North America Chorea Treatment Market Size by Country
6.4.1 North America Chorea Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Chorea Treatment Market Size by Country (2018-2023)
6.4.3 North America Chorea Treatment Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Chorea Treatment Market Size (2018-2029)
7.2 Europe Chorea Treatment Market Size by Type
7.2.1 Europe Chorea Treatment Market Size by Type (2018-2023)
7.2.2 Europe Chorea Treatment Market Size by Type (2024-2029)
7.2.3 Europe Chorea Treatment Market Share by Type (2018-2029)
7.3 Europe Chorea Treatment Market Size by Application
7.3.1 Europe Chorea Treatment Market Size by Application (2018-2023)
7.3.2 Europe Chorea Treatment Market Size by Application (2024-2029)
7.3.3 Europe Chorea Treatment Market Share by Application (2018-2029)
7.4 Europe Chorea Treatment Market Size by Country
7.4.1 Europe Chorea Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Chorea Treatment Market Size by Country (2018-2023)
7.4.3 Europe Chorea Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Chorea Treatment Market Size (2018-2029)
8.2 China Chorea Treatment Market Size by Type
8.2.1 China Chorea Treatment Market Size by Type (2018-2023)
8.2.2 China Chorea Treatment Market Size by Type (2024-2029)
8.2.3 China Chorea Treatment Market Share by Type (2018-2029)
8.3 China Chorea Treatment Market Size by Application
8.3.1 China Chorea Treatment Market Size by Application (2018-2023)
8.3.2 China Chorea Treatment Market Size by Application (2024-2029)
8.3.3 China Chorea Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Chorea Treatment Market Size (2018-2029)
9.2 Asia Chorea Treatment Market Size by Type
9.2.1 Asia Chorea Treatment Market Size by Type (2018-2023)
9.2.2 Asia Chorea Treatment Market Size by Type (2024-2029)
9.2.3 Asia Chorea Treatment Market Share by Type (2018-2029)
9.3 Asia Chorea Treatment Market Size by Application
9.3.1 Asia Chorea Treatment Market Size by Application (2018-2023)
9.3.2 Asia Chorea Treatment Market Size by Application (2024-2029)
9.3.3 Asia Chorea Treatment Market Share by Application (2018-2029)
9.4 Asia Chorea Treatment Market Size by Region
9.4.1 Asia Chorea Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Chorea Treatment Market Size by Region (2018-2023)
9.4.3 Asia Chorea Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Chorea Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Chorea Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Chorea Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Chorea Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Chorea Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Chorea Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Chorea Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Chorea Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Chorea Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Chorea Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Chorea Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Chorea Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Chorea Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Chorea Treatment Introduction
11.1.4 Medtronic Revenue in Chorea Treatment Business (2018-2023)
11.1.5 Medtronic Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Company Details
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Chorea Treatment Introduction
11.2.4 Boston Scientific Revenue in Chorea Treatment Business (2018-2023)
11.2.5 Boston Scientific Recent Developments
11.3 Aleva Neurotherapeutics
11.3.1 Aleva Neurotherapeutics Company Details
11.3.2 Aleva Neurotherapeutics Business Overview
11.3.3 Aleva Neurotherapeutics Chorea Treatment Introduction
11.3.4 Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2018-2023)
11.3.5 Aleva Neurotherapeutics Recent Developments
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Chorea Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Chorea Treatment Business (2018-2023)
11.4.5 Teva Pharmaceutical Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Chorea Treatment Introduction
11.5.4 Pfizer Revenue in Chorea Treatment Business (2018-2023)
11.5.5 Pfizer Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chorea Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Chorea Treatment Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Developments
11.7 Bausch Health Companies
11.7.1 Bausch Health Companies Company Details
11.7.2 Bausch Health Companies Business Overview
11.7.3 Bausch Health Companies Chorea Treatment Introduction
11.7.4 Bausch Health Companies Revenue in Chorea Treatment Business (2018-2023)
11.7.5 Bausch Health Companies Recent Developments
11.8 LivaNova
11.8.1 LivaNova Company Details
11.8.2 LivaNova Business Overview
11.8.3 LivaNova Chorea Treatment Introduction
11.8.4 LivaNova Revenue in Chorea Treatment Business (2018-2023)
11.8.5 LivaNova Recent Developments
11.9 Lundbeck
11.9.1 Lundbeck Company Details
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Chorea Treatment Introduction
11.9.4 Lundbeck Revenue in Chorea Treatment Business (2018-2023)
11.9.5 Lundbeck Recent Developments
11.10 Ipsen
11.10.1 Ipsen Company Details
11.10.2 Ipsen Business Overview
11.10.3 Ipsen Chorea Treatment Introduction
11.10.4 Ipsen Revenue in Chorea Treatment Business (2018-2023)
11.10.5 Ipsen Recent Developments
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Details
11.11.2 Alnylam Pharmaceuticals Business Overview
11.11.3 Alnylam Pharmaceuticals Chorea Treatment Introduction
11.11.4 Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2018-2023)
11.11.5 Alnylam Pharmaceuticals Recent Developments
11.12 Prana Biotechnology
11.12.1 Prana Biotechnology Company Details
11.12.2 Prana Biotechnology Business Overview
11.12.3 Prana Biotechnology Chorea Treatment Introduction
11.12.4 Prana Biotechnology Revenue in Chorea Treatment Business (2018-2023)
11.12.5 Prana Biotechnology Recent Developments
11.13 RespireRx Pharmaceuticals
11.13.1 RespireRx Pharmaceuticals Company Details
11.13.2 RespireRx Pharmaceuticals Business Overview
11.13.3 RespireRx Pharmaceuticals Chorea Treatment Introduction
11.13.4 RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2018-2023)
11.13.5 RespireRx Pharmaceuticals Recent Developments
11.14 Vertex Pharmaceuticals
11.14.1 Vertex Pharmaceuticals Company Details
11.14.2 Vertex Pharmaceuticals Business Overview
11.14.3 Vertex Pharmaceuticals Chorea Treatment Introduction
11.14.4 Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2018-2023)
11.14.5 Vertex Pharmaceuticals Recent Developments
11.15 SOM Biotech
11.15.1 SOM Biotech Company Details
11.15.2 SOM Biotech Business Overview
11.15.3 SOM Biotech Chorea Treatment Introduction
11.15.4 SOM Biotech Revenue in Chorea Treatment Business (2018-2023)
11.15.5 SOM Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Chorea Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Medication
Table 3. Key Players of Surgery Therapy
Table 4. Global Chorea Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Chorea Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Chorea Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Chorea Treatment Market Share by Region (2018-2023)
Table 8. Global Chorea Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Chorea Treatment Market Share by Region (2024-2029)
Table 10. Chorea Treatment Market Trends
Table 11. Chorea Treatment Market Drivers
Table 12. Chorea Treatment Market Challenges
Table 13. Chorea Treatment Market Restraints
Table 14. Global Chorea Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Chorea Treatment Revenue Share by Players (2018-2023)
Table 16. Global Top Chorea Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chorea Treatment as of 2022)
Table 17. Global Chorea Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Chorea Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Chorea Treatment, Headquarters and Area Served
Table 20. Global Key Players of Chorea Treatment, Product and Application
Table 21. Global Key Players of Chorea Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chorea Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Chorea Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Chorea Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Chorea Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Chorea Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Chorea Treatment Revenue Share by Application (2018-2023)
Table 29. Global Chorea Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Chorea Treatment Revenue Share by Application (2024-2029)
Table 31. North America Chorea Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Chorea Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Chorea Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Chorea Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Chorea Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Chorea Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Chorea Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Chorea Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Chorea Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Chorea Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Chorea Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Chorea Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Chorea Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Chorea Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Chorea Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Chorea Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Chorea Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Chorea Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Chorea Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Chorea Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Chorea Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Chorea Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Chorea Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Chorea Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Chorea Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Chorea Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Chorea Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Chorea Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Chorea Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Chorea Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Chorea Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Chorea Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 63. Medtronic Company Details
Table 64. Medtronic Business Overview
Table 65. Medtronic Chorea Treatment Product
Table 66. Medtronic Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 67. Medtronic Recent Developments
Table 68. Boston Scientific Company Details
Table 69. Boston Scientific Business Overview
Table 70. Boston Scientific Chorea Treatment Product
Table 71. Boston Scientific Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 72. Boston Scientific Recent Developments
Table 73. Aleva Neurotherapeutics Company Details
Table 74. Aleva Neurotherapeutics Business Overview
Table 75. Aleva Neurotherapeutics Chorea Treatment Product
Table 76. Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 77. Aleva Neurotherapeutics Recent Developments
Table 78. Teva Pharmaceutical Company Details
Table 79. Teva Pharmaceutical Business Overview
Table 80. Teva Pharmaceutical Chorea Treatment Product
Table 81. Teva Pharmaceutical Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 82. Teva Pharmaceutical Recent Developments
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Chorea Treatment Product
Table 86. Pfizer Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 87. Pfizer Recent Developments
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Chorea Treatment Product
Table 91. GlaxoSmithKline Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 92. GlaxoSmithKline Recent Developments
Table 93. Bausch Health Companies Company Details
Table 94. Bausch Health Companies Business Overview
Table 95. Bausch Health Companies Chorea Treatment Product
Table 96. Bausch Health Companies Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 97. Bausch Health Companies Recent Developments
Table 98. LivaNova Company Details
Table 99. LivaNova Business Overview
Table 100. LivaNova Chorea Treatment Product
Table 101. LivaNova Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 102. LivaNova Recent Developments
Table 103. Lundbeck Company Details
Table 104. Lundbeck Business Overview
Table 105. Lundbeck Chorea Treatment Product
Table 106. Lundbeck Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 107. Lundbeck Recent Developments
Table 108. Ipsen Company Details
Table 109. Ipsen Business Overview
Table 110. Ipsen Chorea Treatment Product
Table 111. Ipsen Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 112. Ipsen Recent Developments
Table 113. Alnylam Pharmaceuticals Company Details
Table 114. Alnylam Pharmaceuticals Business Overview
Table 115. Alnylam Pharmaceuticals Chorea Treatment Product
Table 116. Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 117. Alnylam Pharmaceuticals Recent Developments
Table 118. Prana Biotechnology Company Details
Table 119. Prana Biotechnology Business Overview
Table 120. Prana Biotechnology Chorea Treatment Product
Table 121. Prana Biotechnology Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 122. Prana Biotechnology Recent Developments
Table 123. RespireRx Pharmaceuticals Company Details
Table 124. RespireRx Pharmaceuticals Business Overview
Table 125. RespireRx Pharmaceuticals Chorea Treatment Product
Table 126. RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 127. RespireRx Pharmaceuticals Recent Developments
Table 128. Vertex Pharmaceuticals Company Details
Table 129. Vertex Pharmaceuticals Business Overview
Table 130. Vertex Pharmaceuticals Chorea Treatment Product
Table 131. Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 132. Vertex Pharmaceuticals Recent Developments
Table 133. SOM Biotech Company Details
Table 134. SOM Biotech Business Overview
Table 135. SOM Biotech Chorea Treatment Product
Table 136. SOM Biotech Revenue in Chorea Treatment Business (2018-2023) & (US$ Million)
Table 137. SOM Biotech Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chorea Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Chorea Treatment Market Share by Type: 2022 VS 2029
Figure 3. Medication Features
Figure 4. Surgery Therapy Features
Figure 5. Global Chorea Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Chorea Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Chorea Treatment Report Years Considered
Figure 11. Global Chorea Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Chorea Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Chorea Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Chorea Treatment Market Share by Players in 2022
Figure 15. Global Top Chorea Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chorea Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Chorea Treatment Revenue in 2022
Figure 17. North America Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Chorea Treatment Market Share by Type (2018-2029)
Figure 19. North America Chorea Treatment Market Share by Application (2018-2029)
Figure 20. North America Chorea Treatment Market Share by Country (2018-2029)
Figure 21. United States Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Chorea Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Chorea Treatment Market Share by Type (2018-2029)
Figure 25. Europe Chorea Treatment Market Share by Application (2018-2029)
Figure 26. Europe Chorea Treatment Market Share by Country (2018-2029)
Figure 27. Germany Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Chorea Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Chorea Treatment Market Share by Type (2018-2029)
Figure 35. China Chorea Treatment Market Share by Application (2018-2029)
Figure 36. Asia Chorea Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Chorea Treatment Market Share by Type (2018-2029)
Figure 38. Asia Chorea Treatment Market Share by Application (2018-2029)
Figure 39. Asia Chorea Treatment Market Share by Region (2018-2029)
Figure 40. Japan Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Chorea Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Chorea Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Chorea Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Chorea Treatment Market Share by Country (2018-2029)
Figure 50. Brazil Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Chorea Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Medtronic Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 57. Boston Scientific Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 58. Aleva Neurotherapeutics Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 62. Bausch Health Companies Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 63. LivaNova Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 64. Lundbeck Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 65. Ipsen Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 66. Alnylam Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 67. Prana Biotechnology Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 68. RespireRx Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 69. Vertex Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 70. SOM Biotech Revenue Growth Rate in Chorea Treatment Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs